Clinical trials sponsored by Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

Phase breakdown

Conditions studied

Recruiting trials led by Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

• A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin
  NCT07331389 · Phase: Phase 1 · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location
• A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus
  NCT07082114 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin
  NCT07109700 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone
  NCT07394114 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of HDM2020 in Patients With Advanced Sq-NSCLC
  NCT07638891 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of HDM1005 Compared to Tirzepatide in Obese Adults Without Diabetes
  NCT07521631 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without Diabetes
  NCT07279194 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese Patients
  NCT07036172 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control
  NCT07244003 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Phase II Clinical Study of HDM1005 Injection in Obese Adults Without Diabetes Mellitus
  NCT06886126 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. recruiting for?

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. is the lead sponsor of 10 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.